Literature DB >> 31902084

Impedance drop predicts acute electrical reconnection of the pulmonary vein-left atrium after pulmonary vein isolation using short-duration high-power exposure.

Kyoichiro Yazaki1, Koichiro Ejima2,3, Miwa Kanai1, Shohei Kataoka1, Satoshi Higuchi1, Daigo Yagishita1, Morio Shoda1,4, Nobuhisa Hagiwara1.   

Abstract

PURPOSE: To determine the efficacy and identify the relevant factors for durable lesion creation in pulmonary vein isolation (PVI) using a high-power short-duration (HPSD) strategy.
METHODS: Thirty-two consecutive patients who underwent PVI using HPSD (50 W) (HP group: HP-G) were compared with 32 controls using normal power (25-40 W) (conventional group: C-G). The segments were divided into 12 segments per group; thus, there were 768 segments for analysis. Radiofrequency (RF) ablation (RFA) was mainly performed under guidance with a unipolar electrogram at the distal tip of the ablation catheter in both groups. The high-power strategy reduced radiofrequency energy (P < 0.0001), RFA time (P < 0.0001), acute pulmonary vein reconnection (PVR) segments (P = 0.02), and several three-dimensional-mapping-related indices except for minimum impedance drop (Imp-min).
RESULTS: There was a significant difference only in Imp-min between the subjects with acute PVR and those without in the HP-G (P = 0.002). Multivariate analysis revealed Imp-min to be the only independent predictor of the absence of PVR after adjusting for maximum inter-lesion distance and minimum ablation index (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.07-1.39, P = 0.001). In the region-specific analysis, this was attenuated in posterior segments, where the HP strategy independently predicted the absence of PVR (OR 2.80 [95% CI 1.32-6.30], P = 0.007).
CONCLUSION: The HPSD strategy reduced RF time, RF energy, and three-dimensional mapping-related indices but also improved the acute outcome. The HP strategy may be a sophisticated strategy under guidance with the impedance drop rather than the ablation index.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; High-power short-duration strategy; Impedance drop; Pulmonary vein isolation

Year:  2020        PMID: 31902084     DOI: 10.1007/s10840-019-00691-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.

Authors:  Dibbendhu Khanra; Abdul Hamid; Saurabh Deshpande; Anindya Mukherjee; Sanjiv Petkar; Mohammad Saeed; Indranill Basu-Ray
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

Review 2.  Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation.

Authors:  Xuerong Sun; Jiang Lu; Jinxuan Lin; Tianjie Feng; Ni Suo; Lihui Zheng; Zhimin Liu; Gang Chen; Xiaohan Fan; Shu Zhang; Guodong Niu
Journal:  Cardiol Res Pract       Date:  2021-02-15       Impact factor: 1.866

3.  Esophageal luminal temperature rise during atrial fibrillation ablation is associated with lower radiofrequency electrode distance and baseline impedance.

Authors:  Mirmilad Khoshknab; Ling Kuo; Tarek Zghaib; Jeffrey Arkles; Pasquale Santangeli; Francis E Marchlinski; Yuchi Han; Benoit Desjardins; Saman Nazarian
Journal:  J Cardiovasc Electrophysiol       Date:  2021-05-28       Impact factor: 2.942

4.  Differences between gap-related persistent conduction and carina-related persistent conduction during radiofrequency pulmonary vein isolation.

Authors:  Mark J Mulder; Michiel J B Kemme; Marco J W Götte; Peter M van de Ven; Herbert A Hauer; Giovanni J M Tahapary; Albert C van Rossum; Cornelis P Allaart
Journal:  J Cardiovasc Electrophysiol       Date:  2020-05-22

5.  The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta-analysis study.

Authors:  Yoga Waranugraha; Ardian Rizal; Achmad J Firdaus; Fransiska A Sihotang; Akita R Akbar; Defyna D Lestari; Muhammad Firdaus; Akhmad I Nurudinulloh
Journal:  J Arrhythm       Date:  2021-07-02

Review 6.  Comparison of Effectiveness and Safety between High-Power Short-Duration Ablation and Conventional Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Shuyu Jin; Lu Fu; Junrong Jiang; Xingdong Ye; Huiyi Liu; Yanlin Chen; Sijia Pu; Shulin Wu; Yumei Xue
Journal:  J Interv Cardiol       Date:  2022-08-16       Impact factor: 1.776

7.  Procedural Efficiency, Efficacy, and Safety of High-Power, Short-Duration Radiofrequency Ablation Delivered by STSF Catheter for Paroxysmal Atrial Fibrillation.

Authors:  Cheng Cheng; Banglong Xu; Jianlong Sheng; Zheng Huang; Fei He; Feng Gao; Xiaochen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

8.  Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis.

Authors:  Mohan Li; Yingxu Ma; Qiuzhen Lin; Yunying Huang; Yaozhong Liu; Tao Tu; Qiming Liu
Journal:  Cardiovasc Ther       Date:  2022-07-29       Impact factor: 3.368

9.  Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial.

Authors:  Moloy Das; Armin Luik; Ewen Shepherd; Matthew Sulkin; Jacob Laughner; Tobias Oesterlein; Elizabeth Duffy; Christian Meyer; Pierre Jais; Josselin Duchateau; Arthur Yue; Waqas Ullah; Pablo Ramos; Ignacio García-Bolao
Journal:  Europace       Date:  2021-07-18       Impact factor: 5.214

10.  Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.

Authors:  Chao-Feng Chen; Jing Wu; Chao-Lun Jin; Mei-Jun Liu; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2020-10-27       Impact factor: 2.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.